Immunodepressants in the complex of treatment of the resistant form of radicular pain syndrome in patients with lumbar osteochondrosis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: to evaluate the effectiveness of intravenous drip infusion of glucocorticoid dexamethasone in the complex of treatment of the resistant form of radicular pain syndrome in patients with lumbar osteochondrosis (LO). Methods. A study included 74 LO patients with a resistant form of pain syndrome. The LO was diagnosed according to H. Hall criteria, which included a thorough clinical-neurological examination, functional-spondylographic examination, computed tomography and magnetic resonance imaging of the lumbar spine. To determine the effectiveness of the treatment, 3 scales were used: 1 - determination of the pain syndrome intensity using the visual analogue scale (VAS); 2 - general assessment of the results of treatment by a doctor; 3 - a quantitative assessment of vertebral syndrome. Patients were divided into two groups: group 1 included 37 patients who received intravenous drip infusions of dexamethasone according to the scheme along with traditional conservative therapy; Group 2 (control group) also consisted of 37patients who received only traditional conservative treatment. Results. The intensity of radicular pain syndrome (according to the VAS) in patients of Group 1 after the end of the course of treatment decreased (on average) by 93.8%, in patients of Group 2 - by 65.6%. The duration of the acute period or exacerbation in the Group 1 was 12.4 days, in the Group 2 - up to 60 days. A general assessment of the results of treatment by a doctor showed that a good effect (2-3 points) was obtained in 37 patients of Group 1; none of the patients had lack of effect and worsening. 34 (92%) patients of the Group 2 had unsatisfactory result (0-1 point). A similar result was obtained in the assessment of vertebral syndrome. Discussion. The analysis of the results of the treatment using appointed scales showed that the intensity of the pain syndrome decreased more rapidly in patients of Group 1, the residual pain syndrome did not develop, the significant effect of the therapy was noted in the majority of patients. In patients of Group 2, the intensity of the pain syndrome decreased slightly. The residual pain syndrome developed. Most patients had a moderate effect of treatment, and the vertebral effect persisted for a long time. Conclusion. Comparative analysis shows that the effectiveness of the therapy with intravenous drip infusions of dexamethasone according to the scheme is an effective way to treat the resistant form of pain syndrome in LO.

Full Text

Restricted Access

About the authors

O. Bektoshev

Neurosurgical Department of Samarkand SMA

R. Bektoshev

Neurosurgical Department of Samarkand SMA

Email: Bektoshev@mail.ru
Head of the Neurosurgical Department

M. Ergashev

Neurosurgical Department of Samarkand SMA

A. Yuldasheva

Neurosurgical Department of Samarkand SMA

Sh. Bektoshev

Neurosurgical Department of Samarkand SMA

References

  1. Бектошев Р., Эргашев М., Бектошев О. Мультифакторный патогенез поясничного остеохондроза. Медицинский журнал Узбекистана. 2014;1:16-21.
  2. Бектошев Р.Б., Эргашев М., Бектошев О. Клиническая оценка эффективности применения хондропротекторов в комплексе лечения дистрофических заболеваний (остеохондроз) позвоночника. Медицинский журнал Узбекистана. 2014;1:26-9.
  3. Брода Э. Эволюция биоэнергетических процессов. Пер. с англ. М., 1978.
  4. Васильева И.Г., Хижняк М.В., Шуба И.Н., Гафийчук Ю.Г. Дегенерация межпозвонковых дисков и методы ее биологической коррекции. УНЖ. 2010;1:16-21.
  5. Иванова М.Ф., Евтушенко С.К. Дорсалгия обусловленная дегенеративно-дистрофической патологией позвоночника. Международный неврологический журнал. 2009;3(25):124-29.
  6. Левин О.С. Применение хондропротектора алфлутопа в лечении вертеброгенной люмбоишиалгии. Научно-практическая ревматология. 2003;2:61.
  7. Мендель О.И., Никифоров А.С. Дегенеративные заболевания позвоночника, их осложнение и лечение. РМЖ. 2006;14:4:34-9.
  8. Северина Е.С. Биохимия, учебник для вузов. 2003. 779 с.
  9. Тюкавкина Н.А., Бауков Ю.И. Биоорганическая химия. М., 2005.
  10. Шостак Н.А. Современные подходы к терапии боли в нижней части спины. Consilium Medicum. 2003;5(8):457-61.
  11. Andersson G.B.J. Epidemiological features of chronic low-back pain., Lancet. 1999;354:581-85.
  12. Arnau J.M., Vallano A., Lopez A., Pellise F., Delgabo M.J., Prat N. A critical review of guidelines for low back pain treatment. Eur. Spine. J. 2000;15(5):543-53.
  13. Banks R.A., Bayliss M.T., Lafeber F.P et al. Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. Biochem. J. 1998;30:345-35.
  14. Boos N., Weissbach S., Rohrbach H., et al. Classification of age-related changes in lumbar intervertebral discs 2002 Volvo Award in Basic Science. Spine. 2002;27(23):2631-44.
  15. Carey T.S., Garrett J.M., Jackman A.M. Beyond the good prognosis. Examination of an inception cohort of patients with chronic low back pain. Spine. 2000;25(1):115-20.
  16. Cassidy J.D., Carroll L.J., Cote P The Saskatchewan Health and back pain survey. Spine. 1988;23: 1860-67.
  17. Ehrlich G.E. Low back pain: bulletin of the World Health Organization. 2003;81:671-76.
  18. Hall H. Back pain In: J.N. Noseworthy. Neurological Therapeutis. Martin Dunitz. 2003. Р. 193-207.
  19. Horner H.A., Urban J.PG. Effects of nutrient supply on the viability of cells from the nucleus pulposus of the intervertebral disc: 2001 Volvo Award in Basic Science. Spine. 2001;26(23):2543-49.
  20. Lyons G., Eisenstein S.M., Sweet M.B. Biochemical changes in intervertebral disc degeneration. Biochim. Biophys. Acta. 1981;673:443-53.
  21. Maetzel A., Li L. The economic burden of low back pain: a review of studies published between 1996 and 2001. Best Pract. Pesclin.Rheumatol. 2002;16(1);23-30.
  22. Waddel G. The back pain revolution. Endiburg. Churchil. Livingstone. 1998. С 438.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies